旅遊板塊走高 研究預計今年國內旅遊收入同比增長48%
格隆匯2月24日丨旅遊板塊走高,首旅酒店、華天酒店漲停,騰邦國際漲超9%,西域旅遊、錦江酒店、大東海A、凱撒旅業等大幅走高。中國旅遊研究院最新報吿分析,2021年居民出遊意願將保持在85%以上,旅遊市場復甦步伐勢必更快。預計今年國內旅遊人數、國內旅遊收入分別比上年增長42%和48%。這份《中國旅遊經濟藍皮書(NO.13)》預計,2021年國內旅遊人數41億人次,國內旅遊收入3.3萬億元,分別比上年增長42%和48%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.